PyInvesting

Market research

002393.SHE Tianjin Lisheng Pharmaceutical Co.,Ltd

SHE CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
4B
P/E ratio
28.45
Analyst target
Not available
Dividend yield
5.3%
Beta
-0.07

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Tianjin Lisheng Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 9.1% below its 200 day moving average.

From a valuation standpoint, the stock is 72.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.7.

Tianjin Lisheng Pharmaceutical Co.,Ltd's total revenue sank by 44.5% to $225M since the same quarter in the previous year.

Its net income has dropped by 232.2% to $-71M since the same quarter in the previous year.

Finally, its free cash flow fell by 3500.2% to $-65M since the same quarter in the previous year.

Based on the above factors, Tianjin Lisheng Pharmaceutical Co.,Ltd gets an overall score of 1/5.